Paul Carpenter, MB.BS

Department of Pediatrics
University of Washington
Clinical Director Pediatric Blood and Marrow Transplant Program
Seattle Cancer Care Alliance


B.Sc. Medicine, University of Sydney, Australia
MB.BS., Medicine and Surgery, University of Sydney, Australia

Research Focus:

Dr. Carpenter’s research focus is on acute and chronic graft-vs.-host disease (GVHD), the amelioration of long-term complications associated with GVHD therapies, and the prevention of relapse after transplant in the context of continued immunosuppressive therapy.

Clinical Expertise:

  • Acute GVHD
  • Chronic GVHD
  • Long-term Follow-up of hematologic cell transplant (HCT) survivors

Current Studies

Dr. Carpenter is participating in a multi-site trial that will collect and analyze samples from pediatric HCT patients in order to validate biomarkers of acute and chronic GVHD.  Enrollment recently completed on a phase I/II clinical trial to determine if giving patients nilotinib 100 days after HCT is effective in reducing relapse in patients with Philadelphia chromosome-positive leukemias.   Data analysis is beginning on a national multicenter trial he is leading that compared two chronic graft-versus-host disease drug regimens.

Paul Carpenter, MB.BS

Contact Information

(206) 667-5191
(206) 667-1034
Additional contact

Mail Stop: D5-290